Provided by Tiger Fintech (Singapore) Pte. Ltd.

Verve Therapeutics

10.93
+0.02000.18%
Post-market: 11.020.0880+0.81%19:57 EDT
Volume:2.24M
Turnover:24.59M
Market Cap:976.28M
PE:-5.20
High:11.08
Open:10.96
Low:10.93
Close:10.91
Loading ...
Jul 08, 2022

Correspondence

CORRESP [Cover] - Correspondence
Jul 07, 2022

Major Issues Report

8-K - Current report
Jun 13, 2022

Major Issues Report

8-K - Current report
May 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2022

Major Issues Report

8-K - Current report
Mar 14, 2022

Major Issues Report

8-K - Current report
Mar 14, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 14, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 04, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 04, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 24, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 29, 2021

Major Issues Report

8-K - Current report
Nov 10, 2021

Major Issues Report

8-K - Current report
Nov 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 24, 2021

Major Issues Report

8-K - Current report
Aug 16, 2021

[Rev.]Quaterly Report

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2021

Major Issues Report

8-K - Current report